Article

Candidate Gene and MicroRNA Biomarkers of Metastatic Renal Cell Carcinoma (MRCC) Response to Sunitinib

2022-01-12

Abstract excerpt

<h4>Backgrounds: </h4> The incidence of renal cancer is relatively insidious, and some patients have been metastatic renal cancer at the initial visit. Sunitinib is the first-line systemic therapy for patients with metastatic renal cell carcinoma, however, there is scant analysis of its effect on genes and microRNAs. <h4>Methods: </h4> In this study, 8 differentially expressed microRNAs and 112 differentially expr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 07df8b65-b5fa-595e-9b24-4d6c56aef8e5
DOI: 10.21203/rs.3.rs-1228653/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Candidate Gene and MicroRNA Biomarkers of Metastatic Renal Cell Carcinoma (MRCC) Response to SunitinibDOI 10.21203/rs.3.rs-1228653/v1Read

MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinomaSemantic proximity Read

Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinomaSemantic proximity Read

The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasetsSemantic proximity Read

Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategiesSemantic proximity Read

Identification of Key Genes and Pathways in Renal Cell Carcinoma Through Expression Profiling DataSemantic proximity Read

miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinomaSemantic proximity Read

Renal Cell Carcinoma: A Comprehensive in Silico Study in Searching for Therapeutic TargetsSemantic proximity Read

The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high‐throughput dataSemantic proximity Read

Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA SignatureSemantic proximity Read

Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinomaSemantic proximity Read

Panels of mRNAs and miRNAs for decoding molecular mechanisms of Renal Cell Carcinoma (RCC) subtypes utilizing Artificial Intelligence approachesSemantic proximity Read

Machine Learning Gene Signature to Metastatic ccRCC based on ceRNA NetworkSemantic proximity Read